Faculty Bibliography

INTRODUCTION/BACKGROUND:Previous studies have demonstrated that patients with positive preoperative urine toxicology (utox) screens prior to total joint arthroplasty (TJA) have higher readmission rates, greater complication rates, and longer hospital stays compared to patients with negative screens. The aim of this study was to investigate the effect of postponing surgery for patients with positive preoperative utox in the Medicaid population. METHODS:This retrospective, observational study reviewed the Medicaid ambulatory database at a large, academic orthopedic specialty hospital for patients with a utox screen prior to TJA from 2012 to 2020. Patients were categorized into three groups: (1) controls with negative preoperative utox or a utox consistent with prescription medications (Utox-) with TJA completed as scheduled; (2) positive preoperative utox with TJA rescheduled and surgery completed on a later date (R-utox+); (3) positive preoperative utox inconsistent with prescription medications with TJA completed as scheduled (S-utox+). Primary outcomes included mortality, 90-day readmission rate, complication rate, and length of stay. RESULTS:Of the 300 records reviewed, 185 did not meet inclusion criteria. The remaining 115 patients included 80 (69.6%) Utox-, 5 (6.3%) R-utox+, and 30 (37.5%) S-utox+. Mean follow-up time was 49.6 months. Hospital stays trended longer in the Utox- group (3.7 ± 2.0 days vs. 3.1 ± 1.6 S-utox+ vs.2.5 ± 0.4 R-utox+, p = 0.20). Compared to the R-utox+group, the S-utox+ group trended toward lower home discharge rates (p = 0.20), higher in-hospital complication rates (p = 0.85), and more all-cause 90-day emergency department visits (p = 0.57). There were no differences in postoperative opioid utilization between groups (p = 0.319). Duration of postoperative narcotic use trended toward being longer in the Utox- patients (820.7 ± 1073.8 days vs. 684.6 ± 1491.8 S-utox+ vs. 585.1 ± 948.3 R-utox+, p = 0.585). Surgical time (p = 0.045) and revision rates (p = 0.72) trended toward being higher in the S-utox+ group. CONCLUSIONS:Medicaid patients with positive preoperative utox who had surgeries postponed trended towards shorter hospital stays and greater home discharge rates. Larger studies should be conducted to analyze the implications of a positive preoperative utox on risk profiles and outcomes following TJA in the Medicaid population. Study design Retrospective cohort study.

INTRODUCTION/BACKGROUND:Malnutrition is associated with poorer outcomes after revision total joint arthroplasty (rTJA), though no universal metric for assessing malnutrition in rTJA patients has been reported. This study sought to determine if malnutrition as defined by the Geriatric Nutritional Risk Index (GNRI) can independently predict short-term complication rates and re-revision risk in patients undergoing rTJA. METHODS:All patients ≥ 65 years old undergoing rTJA from 2011 to 2021 at a single orthopaedic specialty hospital were identified. Preoperative albumin, height, and weight were used to calculate GNRI. Based on the calculated GNRI value, patients were stratified into three groups: normal nutrition (GNRI > 98), moderate malnutrition (GNRI 92-98), and severe malnutrition (GNRI < 92). Chi-squared and independent samples t-tests were used to compare groups. RESULTS:A total of 531 rTJA patients were included. Patients with normal nutrition were younger (p < 0.001), had higher BMI (p < 0.001). After adjusting for baseline characteristics, patients with severe and moderate malnutrition had longer length of stay (p < 0.001), were less likely to be discharged home (p = 0.049), and had higher 90-day major complication (p = 0.02) and readmission (p = 0.005) rates than those with normal nutrition. 90-day revision rates were similar. In Kaplan-Meier analyses, patients with severe and moderate malnutrition had worse survivorship free of all-cause re-revision at 1-year (p = 0.001) and 2-year (p = 0.002) follow-up compared to those with normal nutrition. CONCLUSION/CONCLUSIONS:Moderate and severe malnutrition, as defined by GNRI, independently predicted higher complication and revision rates in rTJA patients. This suggests that the GNRI may serve as an effective screening tool for nutritional status in patients undergoing rTJA.

BACKGROUND:Periprosthetic joint infection (PJI) and subsequent revision surgeries may affect patients' social and physical health, ability to complete daily activities, and disability status. This study sought to determine how PJI affects patients' quality of life through patient-reported outcome measures with minimum 1-year follow-up. METHODS:Patients who suffered PJI following primary total joint arthroplasty (TJA) from 2012 to 2021 were retrospectively reviewed. Patients met Musculoskeletal Infection Society criteria for acute or chronic PJI, underwent revision TJA surgery, and had at least 1 year of follow-up. Patients were surveyed regarding how PJI affected their work and disability status, as well as their mental and physical health. Outcome measures were compared between acute and chronic PJIs. In total, 318 patients (48.4% total knee arthroplasty and 51.6% total hip arthroplasty) met inclusion criteria. RESULTS:Following surgical treatment for knee and hip PJI, a substantial proportion of patients reported that they were unable to negotiate stairs (20.5%), had worse physical health (39.6%), and suffered worse mental health (25.2%). A high proportion of patients reported worse quality of life (38.5%) and social satisfaction (35.3%) following PJI. Worse reported patient-reported outcome measures including patients' ability to complete daily physical activities were found among patients undergoing treatment for chronic PJI, and also, 23% of patients regretted their initial decision to pursue primary TJA. CONCLUSIONS:A PJI negatively affects patients' ability to carry out everyday activities. This patient population is prone to report challenges overcoming disability and returning to work. Patients should be adequately educated regarding the risk of PJI to decrease later potential regrets. LEVEL OF EVIDENCE/METHODS:Case series (IV).

INTRODUCTION/BACKGROUND:Preoperative planning of total hip arthroplasty (THA) using two-dimensional low-dose (2DLD) full-body imaging has gained popularity in recent years. The low-dose imaging system is said to produce a calibrated image with constant 1:1 magnification. However, the planning software used in conjunction with those images may introduce variations in the degree of magnification in 2DLD imaging, and this has not yet been investigated. The purpose of the present study was to quantify any variation in 2DLD image to assess the need for image calibration when using conventional planning software. METHODS:Postoperative 2DLD images from 137 patients were retrospectively evaluated. Only patients who underwent THA for primary osteoarthritis were included in the study cohort. The femoral head diameter was measured by two independent observers using both Orthoview™ and TraumaCad™ planning software programs. Actual sizes of the femoral head implants were extracted from surgical reports to calculate image magnification. Magnification measurement reliability was calculated with the intra-class correlation coefficient (ICC) index. RESULTS:Image magnification varied among cases (mean 133%, range 129-135%). There was no statistical difference in mean image magnification among the various implant sizes (p = 0.8). Mean observer and inter-observer reliability was rated excellent. CONCLUSION/CONCLUSIONS:THA planning with 2DLD imaging is subject to variation in magnification as analyzed with conventional planning software in this series. This finding is of paramount importance for surgeons using 2DLD imaging in preparation for THA since errors in magnification could affect the accuracy of preoperative planning and ultimately the clinical outcome.

INTRODUCTION/BACKGROUND:Comparison between fully hydroxyapatite (HA)-coated stems with differing geometry are lacking in the total hip arthroplasty (THA) literature. This study aimed to compare femoral canal fill, radiolucency formation, and 2-year implant survivorship between two commonly used, HA-coated stems. METHODS:All primary THAs performed with two fully HA-coated stems (Polar stem, Smith&Nephew, Memphis, TN and Corail stem, DePuy-Synthes, Warsaw, IN) with a minimum 2-year radiographic follow-up were identified. Radiographic measures of proximal femoral morphology based on the Dorr classification and femoral canal fill were analyzed. Radiolucent lines were identified by Gruen zone. Perioperative characteristics and 2-year survivorship were compared between stem types. RESULTS:A total of 233 patients were identified with 132 (56.7%) receiving the Polar stem (P) and 101 (43.3%) receiving the Corail stem (C). No differences were observed with respect to proximal femoral morphology. Femoral stem canal fill at the middle third of the stem was greater for P stem patients than for C stem patients (P stem; 0.80 ± 0.08 vs. C stem; 0.77 ± 0.08, p = 0.002), while femoral stem canal fill at the distal third of the stem and presence of subsidence were comparable between groups. A total of six and nine radiolucencies were observed in P stem and C stem patients, respectively. Revision rate at 2-year (P stem; 1.5% vs C stem; 0.0%, p = 0.51) and latest follow-up (P stem; 1.5% vs C stem; 1.0%, p = 0.72) did not differ between groups. CONCLUSION/CONCLUSIONS:Greater canal fill at the middle third of the stem was observed for the P stem compared to the C stem, however, both stems demonstrated robust and comparable freedom from revision at 2-year and latest follow-up, with low incidences of radiolucent line formation. Mid-term clinical and radiographic outcomes for these commonly used, fully HA-coated stems remain equally promising in THA despite variations in canal fill.

INTRODUCTION/UNASSIGNED:Bone loss is present in all revision total knee arthroplasties. Metaphyseal cones allow surgeons to negotiate loss of femoral and tibial bone stock while obtaining stable bony fixation. This study examines the mid-term functional and radiographic outcomes in patients undergoing revision total knee arthroplasty (rTKA) utilizing a novel metaphyseal cone system. METHODS/UNASSIGNED:This multicenter retrospective study examined all patients who received a porous, titanium tibial or femoral cone at four academic urban tertiary care institutions and presented for a minimum two-year follow-up. Patient demographics, indications for revision surgery, knee range-of-motion (ROM), re-revision rates, radiographic measurements, bone defect per AORI classification, and implant osseointegration were evaluated according to the Knee Society total knee arthroplasty (TKA) radiographic evaluation system. RESULTS/UNASSIGNED:One-hundred and four patients received 128 cone implants (84 tibial, 44 femoral cones; 24 patients with simultaneous ipsilateral tibial and femoral cones; 104 rTKA) with mean follow-up of 32.75 ± 6.54 months. The pre-operative main revision indications were aseptic loosening 36 (34.61 %), periprosthetic infection (PJI) 23 (22.11 %) and instability 18 (17.3 %). Thirteen rTKA underwent re-revision surgery: 3 for acute PJI, 4 for chronic PJI, 5 for instability, and 1 for mechanical failure of a hinged system. At most recent radiographic follow-up available, all unrevised cones had evidence of osteointegration and no visible implant migration.All-cause re-operation free survivorship was 87.5 % (91/104), and all-cause cone implant survivorship was 96.09 % (123/128 cones) at 2-year follow-up. CONCLUSION/UNASSIGNED:This study demonstrates excellent mid-term outcomes of a novel porous, titanium metaphyseal cone in patients with large bone defects undergoing complex revision TKA. LEVEL OF EVIDENCE/UNASSIGNED:IV, case series.

INTRODUCTION/BACKGROUND:To improve revision total hip arthroplasty (rTHA) prognosis and postoperative management, a better understanding of how non-elective and elective indications influence clinical outcomes is needed. We sought to compare ambulatory status, complication rates, and implant survival rates in patients who underwent aseptic rTHA for periprosthetic fracture or elective indications. MATERIALS AND METHODS/METHODS:This retrospective study examined all aseptic rTHA patients with a minimum follow-up of two years at a single tertiary referral center. Patients were divided into two groups: fracture rTHA (F-rTHA) if the patient had a periprosthetic femoral or acetabular fracture, and elective rTHA (E-rTHA) if the patient underwent rTHA for other aseptic indications. Multivariate regression was performed for clinical outcomes to adjust for baseline characteristics, and Kaplan-Meier analysis was performed to assess implant survival. RESULTS:A total of 324 patients (F-rTHA: 67, E-rTHA: 257) were included. In the F-rTHA cohort, 57 (85.0%) and 10 (15.0%) had femoral and acetabular periprosthetic fractures, respectively. F-rTHA patients were more likely to be discharged to skilled nursing (40.3% vs. 22.2%, p = 0.049) and acute rehabilitation facilities (19.4% vs. 7.8%, p = 0.004). F-rTHA patients had higher 90-day readmission rates (26.9% vs. 16.0%, p = 0.033). Ambulatory status at three months postoperatively significantly differed (p = 0.004); F-rTHA patients were more likely to use a walker (44.6% vs. 18.8%) and less likely to ambulate independently (19.6% vs. 28.6%) or with a cane (28.6% vs. 41.1%). These differences did not persist at one and two years postoperatively. Freedom from all-cause re-revision (77.6% vs. 74.7%, p = 0.912) and re-revision due to PJI (88.1% vs. 91.9%, p = 0.206) were similar at five-year follow-up. CONCLUSIONS:Compared to rTHA performed for elective aseptic indications, fracture rTHA patients had poorer early functional outcomes, with greater need for ambulatory aids and non-home discharge. However, these differences did not persist long term and did not portend increased infection or re-revision rates.

BACKGROUND:The lower morbidity and mortality rate associated with increased surgeon and hospital volume may also correlate with improved patient-reported outcome measures. The goal of this study was to determine the relationship between surgeon and hospital volume and patient-reported outcome measures after total knee arthroplasty (TKA) using American Joint Replacement Registry data. METHODS:Using American Joint Replacement Registry data from 2012 to 2020, 8,193 primary, elective TKAs with both preoperative and 1-year postoperative The Knee Injury and Osteoarthritis Outcome Score, Joint Replacement (KOOS-JR) scores were analyzed. This study was powered to detect the minimally clinical important difference (MCID). The main exposure variables were median annual surgeon and hospital volume. Tertiles were formed based on the median annual number of TKAs performed: low-volume surgeons (1 to 52), medium-volume (53 to 114), and high-volume (≥115); low-volume hospitals (1 to 283), medium-volume (284 to 602), and high-volume (≥603). The mean preoperative and 1-year postoperative KOOS-JR were compared. Multivariable logistic regression models were used to determine the effect of surgeon and hospital volume and demographics on achieving the MCID for KOOS-JR. RESULTS:The mean preoperative and 1-year postoperative KOOS-JR score for low-volume surgeons was 47.78 ± 13.50 and 77.75 ± 16.65, respectively, and 47.32 ± 13.73 and 76.86 ± 16.38 for low-volume hospitals. The mean preoperative and 1-year postoperative KOOS-JR score for medium-volume surgeons was 47.20 ± 13.46 and 76.70 ± 16.98, and 48.93 ± 12.50 and 77.15 ± 16.36 for medium-volume hospitals. The mean preoperative and 1-year postoperative KOOS-JR scores for high-volume surgeons were 49.08 ± 13.04 and 78.23 ± 16.72, and 48.11 ± 13.47 and 78.23 ± 17.22 for high-volume hospitals. No notable difference was observed in reaching MCID for KOOS-JR after adjustment for potential confounders. CONCLUSION/CONCLUSIONS:An increased number of TKA cases performed by a given surgeon or at a given hospital did not have an effect on achieving MCID for KOOS-JR outcomes.

BACKGROUND:Supervised machine learning techniques have been increasingly applied to predict patient outcomes after hip and knee arthroplasty procedures. The purpose of this study was to systematically review the applications of supervised machine learning techniques to predict patient outcomes after primary total hip and knee arthroplasty. METHODS:A comprehensive literature search using the electronic databases MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews was conducted in July of 2021. The inclusion criteria were studies that utilized supervised machine learning techniques to predict patient outcomes after primary total hip or knee arthroplasty. RESULTS:Search criteria yielded n = 30 relevant studies. Topics of study included patient complications (n = 6), readmissions (n = 1), revision (n = 2), patient-reported outcome measures (n = 4), patient satisfaction (n = 4), inpatient status and length of stay (LOS) (n = 9), opioid usage (n = 3), and patient function (n = 1). Studies involved TKA (n = 12), THA (n = 11), or a combination (n = 7). Less than 35% of predictive outcomes had an area under the receiver operating characteristic curve (AUC) in the excellent or outstanding range. Additionally, only 9 of the studies found improvement over logistic regression, and only 9 studies were externally validated. CONCLUSION/CONCLUSIONS:Supervised machine learning algorithms are powerful tools that have been increasingly applied to predict patient outcomes after total hip and knee arthroplasty. However, these algorithms should be evaluated in the context of prognostic accuracy, comparison to traditional statistical techniques for outcome prediction, and application to populations outside the training set. While machine learning algorithms have been received with considerable interest, they should be critically assessed and validated prior to clinical adoption.